![Peter M. Allen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter M. Allen active positions
Companies | Position | Start | End |
---|---|---|---|
N8 Medical, Inc.
![]() N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019. | Director/Board Member | 07/02/2021 | - |
Independent Dir/Board Member | 07/02/2021 | - |
Career history of Peter M. Allen
Statistics
International
United States | 2 |
Operational
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
N8 Medical, Inc.
![]() N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019. | Health Technology |
- Stock Market
- Insiders
- Peter M. Allen
- Experience